Orphazyme A/S ADR (ORPHY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 06-2021 | 12-2020 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 16,269 | 54,171 | 111,366 |
| Receivables | 5,807 | 5,496 | 843 |
| Other current assets | 3,212 | 0 | 7,848 |
| TOTAL | $25,288 | $65,439 | $120,057 |
| Non-Current Assets | |||
| PPE Net | 1,505 | 635 | 1,526 |
| Intangibles | 0 | 356 | 0 |
| Other Non-Current Assets | 933 | 2,955 | 2,954 |
| TOTAL | $2,438 | $3,945 | $4,480 |
| Total Assets | $27,561 | $69,384 | $126,006 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 4,929 | 5,501 | 5,109 |
| Accounts payable and accrued liabilities | 9,152 | 16,045 | 11,051 |
| Other current liabilities | 5,954 | 14,358 | 8,170 |
| TOTAL | $20,539 | $36,255 | $25,527 |
| Non-Current Liabilities | |||
| Long Term Debt | 395 | 2,085 | 3,651 |
| Other Non-Current Liabilities | 4,517 | 2,433 | 250 |
| TOTAL | $5,536 | $6,097 | $5,414 |
| Total Liabilities | $26,075 | $42,352 | $30,942 |
| Shareholders' Equity | |||
| Common Shares | 5,561 | 5,666 | 5,316 |
| Retained earnings | -335,860 | -316,736 | -230,248 |
| Other shareholders' equity | 461 | 531 | 995 |
| TOTAL | $1,486 | $27,032 | $95,064 |
| Total Liabilities And Equity | $27,561 | $69,384 | $126,006 |